The social construction of the biotech industry

New Genetics, New Social Formations

Volumn , Issue , 2006, Pages 94-113

  Birch, Kean ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911125328     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203962893     Document Type: Chapter

References (114)

1. Abraham, J. and Lewis, G. (2000) Regulating Medicines in Europe. London:Routledge.
2. Abraham, J. and Reed, T. (2002) 'Progress, innovation and regulatory science in drug development: the politics of international standard-setting', Social Studies of Science, 32(3):337-69.
3. Abraham, J. and Reed, T. (2003) 'Globalization of Medicines Control', in J. Abraham and H. Lawton Smith (eds), Regulation of the Pharmaceutical Industry. Basingstoke: Palgrave Macmillan.
4. ACARD (with ABRC and The Royal Society) (1980) 'Biotechnology: report of a Joint Working Party (aka The Spinks Report)'. London: HMSO.
5. Acharya, R. (1999) The Emergence and Growth of Biotechnology. Cheltenham:Edward Elgar.
6. Acharya, R., Arundel, A. and Orsenigo, L. (1998) 'The evolution of European biotechnology and its future competitiveness', in J. Senker (ed.), Biotechnology and Competitive Advantage. Cheltenham: Edward Elgar.
7. Audretsch, D. (2003) 'The role of small firms in US biotechnology clusters', in G. Fuchs (ed.), Biotechnology in Comparative Perspective. London: Routledge.
8. Barry, A. and Slater, D. (2005) 'Introduction', in A. Barry and D. Slater (eds), The Technological Economy. London: Routledge.
9. van den Belt, H. and Rip, A. (1987) 'The Nelson-Winter-Dosi model and synthetic dye chemistry', in W. Bijker, T. Pinch and T. Hughes (eds), The Social Construction of Technological Systems. London: MIT Press.
10. BIGT (2003) 'Improving national health, improving national wealth'. London:Bioscience Innovation and Growth Team.
11. Borrus, M. and Stowsky, J. (1997) 'Technology policy and economic growth'. Berkeley, CA: BRIE Working Paper 97.
12. Buctuanon, E. (2001) 'Globalization of biotechnology: the agglomeration of dispersed knowledge and information and its implications for the political economy of technology in developing countries', New Genetics and Society, 20(1):25-40.
13. Callon, M. (1998a) 'Introduction', in M. Callon (ed.), The Laws of the Markets. Oxford: Blackwell Publishers/The Sociological Review.
14. Callon, M. (1998b) 'An essay on framing and overflowing: economic externalities revisited by sociology', in M. Callon (ed.), The Laws of the Markets. Oxford: Blackwell Publishers/The Sociological Review.
15. Callon, M. (1999) 'Actor-network theory-the market test', in J. Law and J. Hassard (eds), Actor-Network Theory and After. Oxford: Blackwell Publishers/The Sociological Review.
16. Carrier, J. (1997) 'Introduction', in J. Carrier (ed.), Meanings of the Market. Oxford: Berg.
17. Carruthers, B. (1996) City of Capital. Princeton, NJ: Princeton University Press.
18. Carruthers, B. and Uzzi, B. (2000) 'Economic sociology in the new millenium', Contemporary Sociology, 29(3):486-94.
19. Casper, S. and Kettler, H. (2001) 'National institutional frameworks and the hybridization of entrepreneurial business models: the German and UK biotechnology sectors', Industry and Innovation, 1:5-30.
20. Chomsky, N. (1997) World Orders, Old and New. London: Pluto Press.
21. Chomsky, N. (1999) Profit over People. London: Seven Stories Press.
22. Chomsky, N. (2000) Rogues States. London: Pluto Press.
23. Cohen, J. (2001) Overdose: the case against the drug companies. New York:Jeremy P. Tarcher/Putnam.
24. Cooke, P. (2003) 'Geographic clustering in the UK biotechnology sector', in G. Fuchs (ed.), Biotechnology in Comparative Perspective. London: Routledge.
25. Coombs, R. and Metcalfe, S. (2002) 'Innovation in pharmaceuticals: perspectives on the co-ordination, combination and creation of capabilities', Technology Analysis and Strategic Management, 14(3):261-71.
26. Coombs, R., Saviotti, P. and Walsh, V. (1987) Economics and Technological Change. London: Macmillan.
27. Coriat, B., Orsi, F. and Weinstein, O. (2003) 'Does biotech reflect a new sciencebased innovation regime?', Industry and Innovation, 10(3):231-53.
28. CRIC (2000) 'Biotechnology in the UK: a scenario for success in 2005'. Manchester:University of Manchester DGRC Report.
29. Cypher, J. (1987) 'Military spending, technical change, and economic growth:a disguised form of industrial policy?', Journal of Economic Issues, 21(1):33-59.
30. Dixon, P. and Greenhalgh, C. (2002) 'The economics of intellectual property: a review to identify themes for future research'. Oxford: Oxford Intellectual Property Research Centre.
31. Dosi, G. (1988) 'Sources, procedures, and microeconomic effects of innovation', Journal of Economic Literature, 26(3):1120-71.
32. Drahos, P. and Braithewaite, J. (2002) Information Feudalism: who owns the knowledge economy. London: Earthscan Publications.
33. DTI (2003) 'Innovation report-competing in the global economy: the innovation challenge'. London: Department of Trade and Industry.
34. Dutfield, G. (2003) Intellectual Property Rights and the Life Science Industries. Aldershot: Ashgate.
35. Easterley, W. (2002) The Elusive Quest for Growth. London: MIT Press.
36. Ernst & Young (2000) 'Evolution: seventh annual European life sciences report 2000'. London: Ernst & Young International.
37. Ernst & Young (2001) 'Integration: eighth annual European life sciences report 2001'. London: Ernst & Young International.
38. Ernst & Young (2003) 'Beyond borders: the global biotechnology report 2003'. London: Ernst & Young International.
39. Evans, J. (2002) Playing God? London: University of Chicago Press.
40. Ferraro, F., Pfeffer, J. and Sutton, R. (2005) 'Economics language and assumptions:how theories become self-fulfilling', Academy of Management Review, 30(1):8-24.
41. Fligstein, N. (1996) 'Markets as politics: a political-cultural approach to market institutions', American Sociological Review, 61:656-73.
42. Florida, R. and Kenney, M. (1988) 'Venture capital-financed innovation and technological change in the USA', Research Policy, 17:119-37.
43. Freeman, C. (1982) The Economics of Industrial Innovation. London: Pinter.
44. Gompers P. and Lerner, J. (1998) 'What drives venture capital fundraising?', Brookings Papers on Economic Activity: Microeconomics:149-204.
45. Gottweis, H. (1998) Governing Molecules. London: MIT Press.
46. Granovetter, M. (1985) 'Economic action and social structure: the problem of embeddedness', American Journal of Sociology, 91(3):481-510.
47. Green, K. (2002) 'Biotechnology, people and markets', New Genetics and Society, 21(2):199-212.
48. Harvey, D. (2003) 'The New Imperialism', Oxford: University of Oxford, Clarendon Lectures in Geography and Environmental Studies.
49. Henwood, D. (2004) 'US miracle is based on longer hours for less pay', The Guardian, 2 February.
50. Hughes, S. (2001) 'Making dollars out of DNA: the first major patent in biotechnology and the commercialization of molecular biology, 1974-80', Isis, 92:541-75.
51. Iwasaka, R. (2000) 'From Chakrabaty to Chimeras: the growing need for evolutionary biology in patent law', Yale Law Journal, 109(6):1505-34.
52. Kaplan, W. and Krimsky, S. (2001) 'Patentability of biotechnology inventions under the PTO utility guidelines: still uncertain after all these years?', The Journal of Biolaw and Business, special supplement.
53. Katz, M. and Ordover, J. (1990) 'R&D cooperation and competition', Brookings Papers on Economic Activity: Microeconomics:137-203.
54. Klein, N. (2001) No Logo. London: Flamingo.
55. Ko, Y. (1992) 'An economic analysis of biotechnology patent protection', Yale Law Journal, 102(3):777-804.
56. Krimsky, S. (1999) 'The profit of scientific discovery and its normative implications', Chicago-Kent Law Review, 75(1):15-39.
57. Krippner, G. (2001) 'The elusive market: embeddedness and the paradigm of economic sociology', Theory and Society, 30(6):775-810.
58. Krugman, P. (1996) Pop Internationalism. London: MIT Press.
59. Kuhlman, G. (1996) 'Alliances for the future: cultivating a cooperative environment for biotech success', Berkeley Technology Law Journal, 11(2):331, 314.
60. Laurie, G. (2003) 'Intellectual property protection of biotechnological inventions and related materials'. Edinburgh: University of Edinburgh, ESRC Innogen Centre.
61. Loasby, B. (2000) 'Organisations as interpretative systems', paper presented at the DRUID Summer Conference, Rebild, Denmark, 15-17 June.
62. MacKenzie, D. (2003) 'Long-term capital management and the sociology of arbitrage', Economy and Society, 32:349-80.
63. MacKenzie, D. and Wajcman, J. (eds) (1999) The Social Shaping of Technology. Buckingham: Open University Press.
64. MacKenzie, M., Keating, P. and Cambrosio, A. (1990) 'Patents and free scientific information in biotechnology: making monoclonal antibodies proprietary', Science, Technology & Human Values, 15(1):65-83.
65. Maebius, S. (1996) 'The new era of process patentability'. Washington, DC: Foley & Lardner.
66. Magdoff, F. (2004) 'A precarious existence: the fate of billions?', Monthly Review, 55(9):1-14.
67. Malinowski, M. (2000) 'Biotechnology in the USA: responsive regulation in the life science industry', International Journal of Biotechnology, 2(1/2/3):16-26
68. May, C. (2000) A Global Political Economy of Intellectual Property Rights. London:Routledge.
69. McKinley, M. (2001) 'Triage: A survey of the "New Inequality" as combat zone', paper presented at the 42nd Annual Convention of the International Studies Association, Chicago.
70. Miller, D. (2002) 'Turning Callon the right way up', Economy and Society, 31(2):218-33.
71. Misa, T. (1997) 'Controversy and closure in technological change: constructing "steel"', in W. Bijker and J. Law (eds), Shaping Technology/Building Society. London: MIT Press.
72. Multinational Monitor (2003) 'Inequality and corporate power', Multinational Monitor, May:8-10.
73. Mowery, D., Nelson, R., Sampat, B. and Ziedonis, A. (2001) 'The growth of patenting and licensing by US universities: an assessment of the effects of the Bayh-Dole act of 1980', Research Policy, 30:99-119.
74. Nelson, R. and Winter, S. (1974) 'Neoclassical vs evolutionary theories of economic growth', Economic Journal, 84:886-905.
75. Nelson, R. and Winter, S. (1982) An Evolutionary Theory of Economic Change. London: Belknap Harvard.
76. Nightingale, P. and Martin, P. (2004) 'The myth of the biotech revolution', Trends in Biotechnology, 22(11):564-9.
77. NIHCM (2002) Changing Patterns of Pharmaceutical Innovation, Washington, DC: National Institute for Health Care Management.
78. OECD (1996) The Knowledge-Based Economy, Paris: Organisation for Economic Cooperation and Development.
79. OECD (2002) Genetic inventions, intellectual property rights and licensing practice. Paris: Organisation for Economic Cooperation and Development.
80. Office of Technology Assessment (1984) Commercial Biotechnology: an international analysis. Washington, DC: US Government Printing.
81. Ordover, J. (1991) 'A patent system for both diffusion and exclusion', Journal of Economic Perspectives, 5(1):43-60.
82. Ossorio, P. (2002) 'Legal and ethical issues in biotechnology patenting', in J. Burley and J. Harris (eds), A Companion to Genethics. Oxford: Basil Blackwell.
83. Owen, G. (2001) 'Entrepreneurship in UK biotechnology: the role of public policy', Working Paper No. 14: The Diebold Institute.
84. Padron, M. and Uranga, M. (2001) 'Protection of biotechnological innovations: a burden too heavy for the patent system', Journal of Economic Issues, 35(2):315-22.
85. Parenti, M. (1995) Against Empire. San Francisco, CA: City Lights Books.
86. Paul, H. and Steinbrecher, R. (2003) Hungry Corporations: Transnational Biotech Companies Colonise the Food Chain. London: Zed Books.
87. Polanyi, K. (1957) 'The economy as instituted process', in K. Polanyi, C. Arensberg and H. Pearson (eds), Trade and Market in the Early Empires. Glencoe, IL: Free Press and Falcon's Wing Press.
88. Polanyi, K. (2001) The Great Transformation. Boston, MA: Beacon Press.
89. Polster, C. (2001) 'How the law works: exploring the implications of emerging intellectual property regimes for knowledge, economy and society', Current Sociology, 49(2):85-100.
90. Poyago-Theotoky, J., Beath, J. and Siegel, D. (2002) 'Universities and fundamental research: reflections on the growth of university-industry partnerships', Oxford Review of Economic Policy, 18(1):10-21.
91. Prevezer, M. (2003) 'The development of biotechnology clusters in the USA from the late 1970s to the early 1990s', in G. Fuchs (ed.), Biotechnology in Comparative Perspective. London: Routledge.
92. Public Citizen (2001) Rx R&D Myths: the Case Against the Drug Industry's R&D 'Scare Card'. Washington, DC: Public Citizen's Congress Watch.
93. Quillen, C. (1992) 'Innovation and the United States patent system today'. Paper presented at Antitrust and Intellectual Property and Policy Issues for the 1990's, Continuing Legal Education Institute.
94. Rasnick, D. (2003) 'The biotechnology bubble machine', Nature Biotechnology, 21(April):355-6.
95. Reenen, J. van (2002) 'Economic issues for the UK biotechnology sector', New Genetics and Society, 21(2):109-30.
96. Robertson, D. (2002) 'US Supreme Court applies strict limits to patents', Nature Biotechnology, 20(July):639.
97. Schumpeter, J. (1939) Business Cycles, Volume 1. London: McGraw-Hill.
98. Sharma, S., Tracy, S. and Kumar, S. (2004) 'The invasion of Iraq: Dollar vs Euro', Z Magazine, February 2004:53-6.
99. Sharp, M. (1996) 'The science of nations: European multinationals and American biotechnology'. Brighton: University of Sussex, STEEP Discussion Paper No. 28.
100. Slaughter, S. and Rhoades, G. (1996) 'The emergence of a competitiveness research and development policy coalition and the commercialization of academic science and technology', Science, Technology & Human Values, 21(3):303-39.
101. Stowsky, J. (1992) 'Conversion to competitiveness: making the most of the national labs', The American Prospect, 3(11).
102. Strange, S. (1998) Mad Money. Manchester: Manchester University Press.
103. Tansey, G. (2002) 'Patenting our food future: intellectual property rights and the global food system', Social Policy and Administration, 36(6):575-92.
104. Thompson, P. (2004) Skating on Thin Ice: the knowledge economy myth. Glasgow:Big Thinking.
105. Thompson, P. and Warhurst, C. (2001) 'Ignorant theory and knowledgeable workers: interrogating the connections between knowledge, skills and services', Journal of Management Studies, 38(7):923-42.
106. Tyson, L. (1992) Who's Bashing Whom? Trade Conflict in High-Technology Industries. Washington, DC: Institute for International Economics.
107. US Congress House Committee on Science and Technology (1981) 'Commercialization of academic biomedical research, hearings before the Subcommittee on Investigations and Oversight, June 8-9', 97th Congress, 1st Session Edition. Washington, DC: US Government Printing Office.
108. Uzzi, B. (1997) 'Social structure and competition in interfirm networks: the paradox of embeddedness', Administrative Science Quarterly, 42:35-67.
109. Valle, F. della and Gambardella, A. (1993) "'Biological" revolution and strategies for innovation in pharmaceutical companies', R&D Management, 23(4):287-302.
110. Vidal, G. (1999) The American Presidency. Monroe, ME: Odonian Press.
111. Walsh, V., Niosi, J. and Mustar, P. (1995) 'Small-firm formation in biotechnology: a comparison of France, Britain and Canada', Technovation, 15(5):303-27.
112. Woiceshyn, J. (1995) 'Lessons in product innovation: a case study of biotechnology firms', R&D Management, 25(4):395-409.
113. Woolgar, S., Coopmans, C., Neyland, D. and Simakova, E. (2005) 'Does STS mean business too?', Paper prepared for Does STS Mean Business Too? Workshop, University of Oxford, 29 June.
114. Wright, S. (1993) 'The social warp of science: writing the history of genetic engineering policy', Science, Technology & Human Values, 18(1):79-101.